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Summary 
The effector functions of CD4 + cells in vivo are presumed to reflect a combination of lympho- 
kine-mediated bystander reactions and direct cytotoxic T lymphocyte activity. To assess the relative 
importance of these two mechanisms, we studied the effects of transferring small doses of purified 
unprimed CD4 + cells to lightly irradiated (600 cGy) recipients expressing major histocompati- 
bility complex class II (Ia) differences.  Within  the first week after transfer,  the host marrow 
was rapidly repopulated  with  hemopoietic cells.  Thereafter,  however,  the donor  CD4 + cells 
caused massive destruction  of hemopoietic cells,  both in marrow and spleen.  Marrow aplasia 
did not affect stromal cells and was prevented by coinjecting donor but not host bone marrow. 
The  use of allotypic markers  and fluorescence-activated cell sorter analysis  indicated  that  the 
destructive effects of CD4 + cells were directed selectively to host Ia + hemopoietic cells, including 
stem cells; donor hemopoietic cells and Ia- host T cells were spared. No evidence could be found 
that the ongoing destruction of host cells impaired the capacity of donor stem cells to repopulate 
marrow, spleen, or thymus. Moreover, CD4 + cells failed to destroy host-type hemopoietic cells 
from h-deficient mice.  Tissue destruction by CD4 § cells thus did not seem to reflect a bystander 
reaction. We conclude that, under defined conditions, CD4 + cells can manifest extremely potent 
h-restricted CTL activity in vivo, probably through recognition of covert Ia expression on stem 
cells  and/or  their immediate progeny. 
C 
TLs play a vital role in many forms of cellular immu- 
nity and are largely responsible for elimination of viruses 
and rejection of allografts (1). Most of the effector cells for 
CTL responses are CD8 + cells. CD4 + cells make an impor- 
tant  contribution  to  CTL  responses,  but  CD4 +  cells  are 
thought to function largely by providing help (lymphokines) 
for  CD8 +  precursor  cells  rather  than  by  acting  as  CTL 
effector cells.  Nevertheless,  there  are a number  of reports 
that, under defined conditions, CD4 + cells do exhibit CTL 
activity (2-9).  The cytotoxic properties of CD4 + cells are 
most  prominent  with  long-term  T  cell clones,  but  CTL 
activity is also seen for primary responses (2, 6). Most cyto- 
toxic CD4 § cells display a Thl phenotype (3, 8).  In mice, 
CTL activity by CD4 + cells generally involves cell contact 
leading  to  apoptosis  (7),  but TNF-mediated  lysis  has  also 
been reported  (9). 
Whether  CD4 + cells  act as CTL under normal  physio- 
logical conditions in vivo is unclear. In terms of allograft re- 
jection (10) and induction of lethal GVHD (11), CD4 + cells 
are known to exhibit potent effector function. The prevailing 
view is  that  the in  vivo effector functions  of CD4 §  cells 
probably reflect a combination of lymphokine-mediated "by- 
stander"  reactions and direct CTL activity (10).  However, 
the relative importance of these two mechanisms is unknown. 
In this paper we investigated whether CD4 § cells mediate 
bystander tissue destruction in vivo by transferring  purified 
CD4 + cells to lightly irradiated MHC class II (Ia)-different 
hosts. The results show that, even in small doses, allogeneic 
CD4 + cells  are capable of causing  massive destruction  of 
host hemopoietic cells, both in spleen and marrow. The sur- 
prising finding, however, is that destruction of hemopoietic 
cells by CD4 + cells seems to be directed solely to host cells 
and not to donor-derived cells.  Moreover, marrow-derived 
cells from h-deficient (knockout) mice are completely resis- 
tant to destruction by aUogeneic CD4 § cells. Tissue destruc- 
tion  by CD4 +  cells  thus  does not  appear  to  reflect a by- 
stander reaction but rather  a highly  potent form of direct 
Ia-restricted  CTL  activity. 
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Mice.  Young adult  B6,  B6.C-H-2  b~12 (bin12), B6.C-H-2  bml 
(bml), D1.LP, B10.A(4R), B10.A(2R), B6 Ly 5.1, B6.PL (Thy 1.1) 
and F1  hybrids between  these strains were obtained from  the 
breeding colony of The Scripps Research Institute. The B6 Ly 5.1 
congeneic line was derived from breeding pairs obtained from the 
National Cancer Institute (Frederick, MD). Ia-deficient mice on 
the B6 background were kindly provided  by Dr. L. Glimcher (Har- 
vard Medical School, Boston, MA) (12). 
Irradiation.  Mice  were exposed to a single dose of y-irradiation 
(80 cGy/min) by an irradiator (Gammacell 40; Atomic Energy of 
Canada, Ottawa,  Canada). 
CellPurification.  As described  elsewhere (13), using RPMI 1640 
or HBSS supplemented  with either 5% FCS or'r-globulin-depleted 
horse serum, highly purified populations of CD4 + cells were pre- 
pared by treating pooled LN with a cocktail of anti-CD8, anti-Ia, 
and anti-heat-stable antigen (HSA) mAbs plus C at 37~  followed 
by positive panning at 4~  on plates coated with anti-CD4 mAb. 
A reciprocal method was used to prepare purified CD8 § cells. 
Bone marrow  (BM)  ~ cells, flushed from  the  leg  bones, were 
depleted of mature T cells by treatment with anti-Thy-1  mAb plus 
C (14). 
Assay for BM aplasia.  Adult (6-16-wk-old) recipient mice ex- 
posed to 600 cGy 4-6 h before were injected intravenously with 
T cells (CD4 + or CD8 + cells), T-depleted (T-) BM cells, or with 
a mixture of T cells and BM cells (14). At various intervals, the 
host mice were killed to measure total numbers of nucleated cells 
in BM (usually  both tibiae) and spleen. Nucleated  cells were enumer- 
ated in 2% acetic acid or by phase-contrast microscopy. 
CFUs.  Using standard techniques (15), the content of CFUs 
in BM was measured by transferring graded doses of T-depleted 
BM cells intravenously to heavily irradiated syngeneic hosts (three 
mice per cell dose). 8-10 d later the recipients were killed and their 
spleens were fixed in Bouin's solution for colony counting. 
FACS |  Analysis.  Using  FITC-conjugated or  unconjugated 
mAbs followed  by FITC-streptavidin, cells were stained for expres- 
sion of Thy 1.2 (Jlj) (15), Thy 1.1 (19E12) (16), Ly 5.1 (A20-1.7), 
and Ly 5.2 (104-2.1) using standard techniques (16). Conjugated 
anti-Ly 5 mAbs were kindly provided by Dr. 13. J. Fowlkes (Na- 
tional Institute of Allergy and Infectious Diseases, Bethesda, MD). 
Dead cells were stained with propidium iodide (Sigma Chemical 
Co., St. Louis, MO) and gated out for analysis. Stained cells were 
analyzed  on a FACScan  |  (Becton Dickinson, Mountain View, CA). 
Results 
In previous studies from this laboratory (The Scripps Re- 
search Institute), we examined the capacity of CD4 + cells 
to cause lethal GVHD in irradiated hosts using the strain 
combination of  B6 and bin12 (14). These two strains are iden- 
tical except for several point mutations in the ~ chain of the 
I-A molecule.  When small doses  of B6  CD4 + cells were 
transferred to lightly irradiated (600  cGy) (B6  x  bm12)Fl 
hosts, the recipients died suddenly from GVHD at 3 wk after 
transfer,  apparently from acute hemopoietic failure.  Other 
workers (17) had reported similar findings for h-different mice 
injected with unseparated T cells. The surprising finding was 
that acute GVHD in lightly irradiated (B6  x  bm12)Fl hosts 
failed  to  occur when B6  CD4 +  cells  were  supplemented 
1 Abbreviation used in this paper: BM, bone marrow. 
with donor BM cells or a mixture of donor and host BM 
cells (14). 
The initial aim of the experiments outlined below was to 
determine why the  presence  of donor  BM  cells  prevents 
CD4 + cells from mediating lethal GVHD in lightly irradi- 
ated Ia-different hosts.  Unless  stated otherwise,  doses  of 
2  x  106  highly purified LN  CD4 §  cells  were  transferred 
intravenously to adult (B6  x  bm12)F1 hosts exposed  to a 
low dose of 600 cGy 4-6 h before; BM cells (2  x  106) were 
T-depleted and were injected alone or as a mixture with T cells. 
Acute Lethal GVHD Induced by CD4 + Cells in Lightly Ir- 
radiated Ia-different Hosts Reflects BM Aplasia.  When a dose 
of 2  x  106  B6  CD4 +  cells  was  transferred to  600  cGy 
(B6  x  bml2)Ft hosts, the mice became acutely ill  16-18 d 
after transfer and died several days later. This was an invari- 
able finding (seen in >10 experiments) and death rates were 
virtually 100%. When the mice were killed at days 16-18, 
the mice were obviously anemic and numbers of white blood 
cells and erythrocytes in peripheral blood were markedly re- 
duced (data  not shown). This pancytopenia was associated 
with striking atrophy of the host marrow, the numbers of 
nucleated cells in the long bones (tibiae)  being reduced by 
20-200-fold relative  to mice treated with irradiation alone 
(Table 1). Splenic atrophy was moderate on day 16 (Table 1) 
but was marked by days  18-21  (see below). 
Supplementing the injected B6 CD4 § cells with host F1 
(Table  1) or bm12 BM cells (see below) had no effect on 
BMApleen atrophy and failed to prevent death. However, 
adding donor BM cells, or a mixture of donor and host BM 
cells, caused minimal BM atrophy and resulted in prominent 
splenomegaly and virtually complete protection against death 
(Table 1). 
In hosts injected with B6 CD4 + cells in the absence of 
B6 stem cells, histological examination of the host long bones 
at days 16-18 revealed an almost complete absence of  nucleated 
hemopoietic cells in the marrow cavities  (Fig.  1,  b and at). 
It is significant, however, that the stromal cells in the marrow 
were  well  preserved.  When  B6  CD4 +  cells  were  sup- 
plemented with B6 BM cells or a mixture of B6 and either 
F1 or bm12 BM cells, there was no evidence of marrow at- 
rophy and the marrow was filled with dense accumulations 
of hemopoietic cells (Fig.  1, a and c). In this situation, the 
histology of the  marrow was  indistinguishable from  the 
marrow of control mice given 600 cGy alone (data not shown). 
The dose of B6 CD4 § cells required to induce BM at- 
rophy in irradiated (B6  x  bm12)F1 hosts was surprisingly 
low, since as few as 7  x  104 cells were sufficient  to cause 
complete atrophy (Fig. 2 a). As a control for these studies 
with B6  CD4 § cells, we examined the dose of B6  CD8 § 
cells required  to  cause  host marrow  atrophy in  600  cGy 
(B6  x  bml)F1 hosts (Fig.  2 b).  In this strong MHC class 
I-different combination, induction of  marked marrow atrophy 
necessitated  injecting in  the order of 3  x  10  s B6  CD8 + 
cells, i.e.,  fourfold more cells than were needed for CD4 + 
cells in the B6 --~ bin12 combination. 
As shown in Table 2, Exp. 1, the capacity of CD4 + cells 
308  Destruction  of Stem Cells by CD4 + Cells Table  1.  BM Counts and Spleen  Weights  of Irradiated (B6  x  bm12)F, Hosts Injected 16 d before with B6 CD4 + 
Cells Plus Donor vs.  Host BM Cells 
No.  of nucleated cells 
Cells transferred to  600  (￿  10 -6)  (SD)  in  Spleen weight  Incidence 
cGy (B6  ￿  bm12)F1  host marrow  (both  (mg)  (SD)  at  of lethal 
hosts  tibiae) at  day  16  day  16  GVHD 
% 
B6  CD4 +  0.1  (< 0.1)  58  (11)  100 
B6  CD4 §  +  F1 BM  0.1  (< 0.1)  63  (9)  100 
B6  CD4 §  +  B6  BM  10.5  (6.3)  578  (524)  0 
B6  CD4 §  +  B6  BM  +  F1 BM  10.9  (0.8)  467  (201)  0 
B6  BM  16.2  (1.1)  84  (5)  0 
No cells  15.9  (2.4)  86  (6)  0 
Purified LN CD4+  cells and T-depleted BM cells (2  x  106 of each population)  were transferred intravenously 4-6 h after irradiation of the hosts. 
The data  (mean of three to five mice tested individually) are from a single experiment  and are representative  of several other experiments. 
Figure  1.  Histology of BM aplasia. (B6  x  bm12)F1 mice were exposed to 600 cGy and injected with B6 CD4 § cells plus a mixture of B6 and 
bm12 BM cells (2  x  106 of each) (a and c)'or with B6 CD4 + cells  plus bm12 BM cells (b and d). After  16 d, femurs from the two groups of mice 
were decalcified; sections were prepared and stained with hematoxylin and eosin. (a and c) Low and high power views of femur from a mouse given 
B6 CD4 + cells plus B6 BM plus bm12 BM cells. The marrow  is filled with nucleated hemopoietic  cells. (b and d) Low and high power views of 
femur from a mouse given B6 CD4 + cells plus bm12 BM cells. The marrow is largely devoid of nucleated hemopoietic cells, but the stromal cells 
are well preserved. (a and b)  xl00; (c and d)  x400. 
309  Sprent et al. B6 CD4  + cells transferred  B6 CD8  + cells transferred  a 
to (B6 x brnl2)F 1 hosts  to (B6 x bml)F 1 hosts 
25- 
20- 
15- 
lO- 
t3  5- 
n 
Table  2.  t 
0  .08  .2  .7  2  7  20  0  1  3  10  30 
NO. of B6 CD4 +  cells tlansferred (xl0 -5)  No. of B6 CD8 + cells Wansferred (xl0 -5) 
Figure  2.  Dose orB6 CD4 + cells required to 
induce marrow atrophy in (B6  x  bml2)F1 hosts. 
(a) Total numbers of nucleated cells recovered from 
both tibiae of 600 cGy (B6  x  bml2)F1 mice in- 
jected 16 d before with graded doses of B6 CD4 + 
cells. (b) Total numbers  of nucleated  cells recov- 
ered from both tibiae of 600 cGy (B6  x  bml)Fl 
mice injected 14 d before with graded doses of B6 
CD8 + ceils. Mean  of data from three  mice per 
group tested individually. 
Induction of Marrow Atrophy by CD4 § Cells in 600 cGy (136  x  bml2)F1 Hosts Requires Recognition of Host la Antigens. 
No.  of nucleated cells 
(x  10 -6)  (SD) in 
Exp.  Hosts  Target  both  tibiae at  days 
No.  Cells transferred  (600  cGy)  antigen  15-18 
1  D1.LP  CD4 §  (B6  x  bm12)Ft  I-A  bm12  0.5  (0.1) 
D1.LP  CD4 +  +  D1.LP  BM  I-A  bin12  23.2  (2.9) 
bin12  CD4 +  bA  h  0.9  (0.2) 
bin12  CD4 +  +  bm12  BM  I-A  b  19.0  (3.2) 
No cells  -  17.3  (3.3) 
2  B6  CD4 +  (B6  x  bml2)Fi  I-A  bin12  0.3  (0.1) 
(B6  x  bml2)F1  CD4 +  -  16.6  (2.4) 
Chimera B6  CD4 +  I-A  bmlz  16.7  (3.7) 
No cells  -  15.0  (2.4) 
3  B6  CD4 +  (B6  x  bml2)F1  I-A  bin12  0.1  (<0.1) 
B6  CD8 +  I-A  bm12  9.4  (1.8) 
No cells  -  9.4  (1.2) 
4  B6  CD4 +  (B6  x  4R)F1  I-A  k  1.2  (0.6) 
B6  CD4 §  +  B6  BM  I-A  k  20.3  (3.9) 
4R  CD4 +  I-A  b  1.3  (0.5) 
4R CD4 +  +  4R BM  I-A  b  24.0  (1.7) 
No cells  -  21.6  (2.5) 
5  4R  CD4 +  2R  I-E  k  1.7  (0.4) 
4R CD4 +  +  4K BM  I-E  k  25.3  (4.7) 
No cells  -  22.0  (0.8) 
6  B6  CD8 §  cells  (B6  x  bml)Ft  K bin1  0.2  (0.1) 
B6  CD4 §  cells  K bin1  20.3  (1.9) 
No cells  -  18.3  (6.0) 
Host mice were exposed  to 600 cGy and  injected  with purified  CD4§  cells (2  x  106/mouse)  _+  syngeneic BM cells (2  x  10~/mouse);  chimera 
B6 CD4 + cells were prepared  from LN of heavily irradiated  (1,100  cGy) (B6  x  bm12)F1 mice injected  6 mo previously  with T-depleted  B6 BM 
cells. BM counts refer to the mean data  from three mice/group. 
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in both  tibiae 
day  16 
Cells injected into  600  cGy 
(B6  x  bml2)F1  hosts  day 2  day 7 
/t 
E 
L) 
-  1.0  (0.8)  18.0  (2.0)  20.2  (4.2) 
FI BM  (2  x  106)  2.0  (1.1)  20.6  (1.6)  23.4  (7.4) 
F1  BM  (2  x  106)  +  B6  CD4 §  1.1  (0.1)  20.4  (2.9)  0.2  (0.1) 
F,  BM  (2  x  107 )  +  B6  CD4 +  -  17.3  (2.2)  0.4  (0.2) 
B6  CD4 §  1.3  (0.2)  15.8  (3.3)  0.3  (0.2) 
As for Table  1, three mice per group.  CD4+  cells were injected in a dose  of 2  x  106 cells/mouse. 
to induce host marrow atrophy in irradiated (B6  x  bml2)F1 
hosts applied to both parental  strains  and also extended to 
D1.LP  (I-A  b) CD4 + ceils  (B6  and D1.LP  are MHC  iden- 
tical but have different genetic backgrounds).  Recognition 
of host antigens appeared to be essential because no marrow 
atrophy was observed when (B6  x  bm12)F1 hosts were in- 
jected  with  host  F1  CD4 §  cells  or  with  B6  CD4 +  cells 
tolerized  to host antigens  in B6  BM  -*-  1100 cGy  (B6  x 
bm12)F1  chimeras  (Table  2,  Exp.  2).  In  terms  of T  cell 
subsets, marrow atrophy in (B6  x  bm12)F1 hosts was re- 
stricted to CD4 § cells:  no atrophy occurred with injection 
of B6  CD8 +  cells  (Table  2,  Exp.  3). 
In addition to the B6/bm12 combination, CD4 § cells in- 
duced marked  marrow  atrophy  in  a  number  of other  Ia- 
different strain combinations, including strains with isolated 
allelic  I-A differences (4R --- B6, B6 -+ 4R) and I-E differ- 
ences (4R ~  2R) (Table  2, Exp. 4  and 5).  Ia disparity ap- 
peared to be essential because B6 CD4 + ceils failed to cause 
marrow  atrophy  in  class  I-different  (B6  x  bml)F1  hosts 
(Table  2,  Exp.  6). 
In all of the above situations, marrow atrophy in Ia-different 
hosts only applied when  CD4 +  cells were  injected in the 
absence  of donor BM  cells.  When  CD4 +  cells  were  sup- 
plemented with syngeneic donor BM cells, marrow atrophy 
was mild or undetectable  (Table  2). 
Kinetics of  Marrow Aplasia.  The above data refer to marrow 
counts measured 14-18 d after transfer  of CD4 + ceils.  The 
kinetics  of the onset of marrow aplasia  are shown in Table 
3 and Fig. 3. When (B6  x  bm12)F1 mice were treated with 
600 cGy alone, the cellularity of the marrow on day 2 was 
reduced by  10-20-fold  relative  to unirradiated mice  (Table 
3). Thereafter,  cell counts in the marrow increased progres- 
sively to reach  near-normal levels by days  7-12  (indicating 
repopulation by radioresistant host stem cells).  When  600 
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Table  3.  Marrow Aplasia  Induced by CD4 §  Cells Develops Late and Is Not Apparent  during the First 7  d after Transfer 
20 
Time after transfer (d) 
Figure  3.  Kinetics of marrow and spleen atrophy in irradiated (B6  x  bml2)F: mice given B6 CD4 + cells. Groups of (B6  x  bm12)Fl  mice were 
exposed to 600 cGy and injected with 2  x  106 F1 BM cells (O) or a mixture of 2  x  106 B6 CD4 + cells and 2  x  106 F1 BM cells (O). Total numbers 
of nucleated cells in BM (both tibiae) (a), spleen (b), and spleen weights (c) were then measured at 2-d intervals. In a separate experiment (d), spleen 
weights in 600 cGy (B6  x  bm12)F1 mice were measured at various stages after transferring 2  x  106 B6 BM cells (VI) or 2  x  106 B6 CD4 + cells 
and 2  x  106 B6 BM cells (1).  In this experiment,  spleen weights in mice given B6 CD4 + cells and B6 BM cells returned to near normal levels 
by day 30.  The data represent the mean of three mice per group. 
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or with F1 BM cells, the increase in marrow counts between 
days 2 and 7 was the same as in uninjected irradiated mice, 
indicating that CD4 + cells did not prevent initial repopula- 
tion of the host marrow. Between days 7 and 16, however, 
the cellularity of the marrow dropped precipitously. Adding 
large doses of F1 BM cells (2  x  107) failed to prevent this 
late onset of marrow atrophy (Table 3). 
When the cellularity of the marrow was measured at 2-d 
intervals, the onset of marrow atrophy in F1 mice given B6 
CD4 + cells (data not shown) or B6 CD4 + cells plus F1 BM 
cells (Fig. 3 a) first became evident 8-10 d after transfer. There- 
after marrow counts declined abruptly and reached very low 
levels by day 12.  Similar kinetics applied to cell counts in 
spleen (Fig. 3 b). Spleen weights were mildly increased rela- 
tive to uninjected control mice 6-10 d after transfer and then 
decreased to below the control levels after day 14 (Fig. 3 c). 
This applied to B6 CD4 + cells transferred in the absence of 
B6  BM  cells.  When  B6  CD4 §  cells  were  supplemented 
with syngeneic B6 BM cells, massive splenomegaly occurred: 
spleen weights were maximal ~2 wk after transfer and then 
gradually declined towards normal levels over the next 2-3 
wk (Fig. 3 d and data not shown); marrow counts remained 
close to control levels throughout the period studied (data 
not  shown). 
Marrow Aplasia Includes Stem Cells.  To examine whether 
the destruction of host marrow cells by CD4 + cells included 
stem cells, the few cells remaining in the host marrow at 14 d 
after transfer were assayed for CFUs using standard proce- 
dures (see Materials and Methods);  the cells  (pooled from 
9 mice) were treated with anti-Thy-1 mAb plus C  before 
transfer to remove mature T cells. As shown in Table 4, Exp. 
1,  the total content of CFUs  in the hind legs  of F1 mice 
injected with B6 CD4 + cells  (without B6 BM cells)  was 
reduced by about 300-fold relative to marrow cells recovered 
from uninjected irradiated control mice. To determine whether 
the destruction of stem cells applied to pluripotential stem 
cells,  host BM cells harvested from a group of 20 F1 host 
mice injected 15 d before with B6 CD4 + cells were T-de- 
pleted and then tested for their capacity to protect lethally 
irradiated (1,100 cGy) F1 mice. Of three mice injected with 
a  dose  of 5  x  105 BM  cells,  two  mice died  3  wk  after 
transfer and one mouse survived. With control BM cells from 
mice treated with irradiation alone, a dose of 5  x  10  s cells 
led  to  100%  survival and  10  s cells  caused 80%  survival. 
These data imply that the residual marrow cells harvested 
from F1 mice given B6 CD4 + cells were largely depleted of 
pluripotential stem cells. 
Marrow Aplasia Induced by CD4 + Cells Is Associated with 
Migration of Donor T Cells into the Host Marrow.  To examine 
whether the donor CD4 + cells entered the host long bones, 
600 cGy (B6  x  bm12)F1 hosts (Thy 1.2) were injected with 
B6.PL (B6-Thy-l.1) CD4 + cells. When the cells recovered 
from the host marrow were analyzed by FACS  |  at days 14-16, 
40-70% of the few nucleated cells recovered were Thy 1.1 + 
(Table 4, Exp. 2); 5-10% of the cells were Thy 1.2 + . These 
findings  indicate that the donor CD4 § cells did indeed reach 
the marrow of the host. Donor (Thy 1.1 +) CD4 + cells were 
also  evident in the spleen (10-20% Thy 1.1 + cells by day 
18) (data not shown). With regard to host cells, the few viable 
cells recovered from the spleen 16-18 d  after transfer con- 
sisted  predominantly of radioresistant  host  (Thy  1.2 +)  T 
Table 4.  CFUs and Donor T  Cells in Aplastic Marrow  from Irradiated (136 x  bml2)Fl Mice Injected with B6 CD4 + Cells 14 d before 
Exp  Treatment of  Cells recovered from host  marrow 
No.  (B6  x  bm12)F1 hosts  at day 14 
1  No. of nucleated  CFUs/106  cells  Total CFUs  in 
cells in both  both hind legs 
hind legs 
-  42  x  106  66  2,772 
600 cGy  32  ￿  106  32  1.024 
600 cGy  +  B6 CD4 + cells  0.5  ￿  106  6  3 
2  %  Thy 1.1 §  %  Thy 1.2 + 
cells in  cells in 
marrow  marrow 
~2  4 
65  7  600 cGy  +  B6.PL CD4 § cells 
In Exp. 1, pooled  marrow cells were treated with anti-Thy 1.2 mAb plus C to remove  mature T cells and then transferred  in graded doses to 1,000 
cGy B6 mice to measure spleen colonies on day 8. Similar data were observed in another experiment where CFUs were measured on day 10. In 
Exp. 2, pooled  marrow cells were analyzed  by FACS  |  for expression  of Thy 1.1+ cells and Thy 1.2+ cells  using standard procedures (See  Materials 
and Methods). 
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(data not shown). Host T  cells were also evident in marrow 
(Table 4). 
Marrow  Destruction  by  CD4 +  Cells  Is  Restricted  to  Host 
Cells.  As  mentioned  earlier,  marrow  aplasia  induced by 
CD4 § cells was mild or absent when the donor CD4 + cells 
were supplemented with donor BM cells or a mixture of donor 
and host BM cells. The simplest explanation for this finding 
is that the donor CD4 + cells destroyed host BM cells but 
spared donor BM cells. Alternatively, the presence of donor 
BM-derived cells might somehow have inhibited the destruc- 
tive effects  of the donor CD4 + cells. 
To distinguish between these two possibilities, 600 cGy 
(B6  x  bm12)F1  mice (Ly 5.2) were injected with BM cells 
from the B6-Ly 5.1 congeneic line (Ly 5.1) with or without 
B6 CD4 + cells (Ly 5.2). In terms of total cell counts in the 
marrow, both groups of recipients showed no evidence of 
marrow aplasia  when tested 14-35 d  after transfer. When 
the donor/host identity of the marrow cells was assessed by 
FACS  |  analysis,  the recipients of B6-Ly 5.1 BM cells alone 
comprised a mixture of Ly 5.1 § (donor) and Ly 5.2 + (host) 
cells in both marrow and spleen.  With injection of a mix- 
ture  of B6-Ly 5.1  BM  and  B6  CD4 +  cells,  by contrast, 
nearly all of the Thy 1-  cells in the host marrow were Ly 
5.1 + . 
This is illustrated in the experiment shown in Fig. 4 in 
which a limiting dose of 2  x  10  s B6-Ly 5.1 BM cells was 
used for reconstitution. With this small dose of BM calls, 
reconstitution of the host marrow with donor Ly 5.1 + calls 
was quite limited (11% Ly 5.1 + cells 4 wk after transfer). 
In marked contrast, in recipients of a mixture of B6 CD4 + 
cells and the same small dose of B6-Ly 5.1 BM cells, nearly 
all (93%) of the Thy 1-  marrow cells were Ly 5.1 + (com- 
pared with 95% staining of normal B6-Ly 5.1 BM). Reciprocal 
results were observed when the marrow from the two groups 
of mice were stained for host Ly 5.2 expression. Bearing in 
mind that the anti-Ly 5.2 mAb used caused weak (6%) cross- 
reactive staining of normal B6-Ly 5.1 marrow (Fig. 4), Thy 
1-  host Ly 5.2 + cells were virtually absent in in the mice 
given a mixture of B6 CD4 + calls and B6-Ly 5.1 BM cells. 
Similar findings applied to the Thy 1- T cells in spleen (Fig. 
4). As a control in this experiment, some of the mice were 
injected with B6-Ly 5.1 BM cells plus bin12 CD4 + cells and 
bin12 BM ceils (both Ly 5.2). The expectation here was that 
the bin12 CD4 + cells would kill the allogeneic B6-Ly 5.1 
BM cells (and also host F1 BM cells) but spare the syngeneic 
bm12 BM cells, thus causing complete repopulation with Ly 
5.2 + cells, i.e., with bm12-derived cells. This was indeed the 
case (Fig.  4). 
The data in Fig.  4 indicate therefore that, in the presence 
of a mixture of donor and host BM cells, donor CD4 + cells 
selectively destroyed host BM-derived cells.  The recipients 
thus showed complete repopulation with donor-derived cells. 
CD4 + Cells Destroy Host Precursors of Thymocytes.  Thy- 
Normal 
B6 Ly 5,1 
mouse 
Normal 
(B6 x  bm121F 1 
mouse 
B6 Ly 5.1  BM 
-~ 600 cGy  F  1 
B6 Ly 5.1  8M 
+  B6 CD4 + 
-~ 600 cGy F  1 
Cells  from  recipients'  BM 
Ly 5.2 
6.2  \ 
7.4 
B6 Ly 5.1  BM  I  I~  95.1~ 
+  bm12 CD4 + 
+  bin12  BM 
-~ 600 cGy  F  1 
Ly 5.1 
0.9 
Cells  from  recipients'  spleen 
Ly 5.2 
12.. 
Ly 5.1 
~ 
_  0.6 I 
1 
Figure 4.  Donor  CD4 §  cells 
destroy host hemopoietic  cells but 
spare donor cells. (B6 x bm12)Ft 
mice (1..7 5.2) were exposed  to 600 
cGy and reconstituted  with a low 
dose of 2  x  10  s B6-Ly 5.1 BM 
cells with or without 2 x  106 B6 
(Ly  5.2) CD4 + cells. A control 
group of mice received  B6-Ly 5.1 
BM cells supplemented  with bm12 
CD4 + cells and bm12 BM cells. 
Using cells pooled from two to 
three mice per group, marrow and 
spleen suspensions  were  prepared  4 
wk after  transfer, treated  with anti- 
Thy I mAb plus C to remove  ma- 
ture T cells and stained for expres- 
sion of Ly 5.1 and Ly 5.2 followed 
by FACS  |  analysis. The data are 
plotted on a log scale. 
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Figure  5.  Donor CD4 + cells destroy host precursors of thymocytes. 
(B6  x bm12)F1 mice exposed to 600 cGy were injected with a low dose 
of 2 x  10  s B6.PL (Thy 1.1) BM cells with or without 2 x  106 B6 (Thy 
1.2) CD4 + cells. Pooled thymocytes from both groups of mice (40-60 
X  106/mouse) were stained for expression of Thy 1.1 vs. Thy 1.2 4 wk 
after transfer and then analyzed with a FACS  |  The data are plotted on 
a log scale. 
mocyte repopulation in irradiated mice is known to depend 
upon a constant influx of stem cells, probably pluripotential 
stem cells, from the marrow (18). To examine whether thymic 
cells  can  act  as  targets  for  CD4 +  cells,  600  cGy (B6  ￿ 
bm12)Ft mice (Thy 1,2) were reconstituted with a low dose 
of 2  ￿  105 B6-Thy 1.1  BM cells  +  B6 CD4 + cells  (Thy 
1.2).  When thymocytes from the two groups of mice were 
analyzed by FACS  |  4 wk later, thymocytes from the control 
group given B6-Thy 1.1 BM cells  alone contained very few 
donor BM-derived cells,  i.e.,  4% Thy 1.1 + cells (Fig. 5). In 
marked contrast, donor-derived Thy 1.1 + cells accounted for 
virtually all of the thymocytes recovered from recipients  of 
a  mixture  of B6-Thy  1.1  BM  and  B6  CD4 §  cells.  This 
finding implies  that the injected B6 CD4 + cells  selectively 
destroyed host  stem cells,  thereby allowing the  thymus to 
be repopulated  solely by donor stem cells. 
Resistance  of Ia-  BM Cells to Destruction  by CD4 + Cells. 
The above data on phenotyping of marrow cells and thymo- 
cytes indicate that the destructive function of CD4 § cells is 
strongly Ia restricted and is directed, at least in part, to stem 
cells.  The key problem with this scenario is that despite ex- 
Table  5.  Resistance of B6 Ia ~ BM Cells to Destruction by bin12 CD4 + Cells 
Cells  transferred  to 
600 cGy hosts 
Exp. 
No.  T  cells  BM cells 
Spleen/BM recovered from 
hosts at  days  14-16 
No.  of nucleated 
cells in both  tibiae  Spleen weight 
(x  10 -6) (SD)  (rag)  (SD) 
1  bm12 CD4 §  bm12 
bin12 CD4 §  B6 
bm12 CD4 §  B6 Ia  ~ 
B6 CD4 +  bin12 
B6 CD4 §  B6 
B6 CD4 +  B6 Ia  ~ 
2  bm12 CD4 §  bm12 
bm12 CD4 §  B6 
bm12 CD4 +  B6 Ia  ~ 
-  B6 
-  B6  Ia ~ 
(B6  x  bml2)F1 hosts 
19.7 (1.0)  166 (32) 
0.8  (0.1)  80 (2) 
23.1  (6.8)  220 (19) 
1.1  (0.1)  69 (5) 
22.5  (5.8)  230 (32) 
23.3  (6.0)  204 (64) 
19.8 (7.4)  126  (8) 
0.1  (<0.1)  38 (3) 
20.2  (2.7)  183 (110) 
20.1  (2.4)  76  (2) 
24.3  (0.6)  72 (6) 
(B6  ￿  bml)Fl hosts 
bml CD8*  B6  1.2 (0.2)  43  (9) 
bml CD8 +  B6 Ia  ~  0.3  (0.2)  50 (12) 
-  B6  Ia ~  21.4  (4.5)  77  (1) 
In each experiment, T cells and BM cells were injected in a dose of 2  x  106 cells/mouse. The mice were analyzed at 14--16 d after transfer. The 
data represent the mean of three mice per group. 
314  Destruction of Stem Cells by CD4 + Ceils haustive attempts we were unable to demonstrate Ia expres- 
sion on stem cells.  Thus,  even after incubation  with lym- 
phokines in vitro,  treating marrow cells with anti-Ia mAb 
plus C and/or removing Ia + cells by panning failed to cause 
any significant reduction in CFUs or remove pluripotential 
stem cells (data not shown). Since the above methods might 
not be sufficiently sensitive to detect limited (but physiologi- 
cally significant)  Ia expression on stem cells,  we examined 
whether CD4 + cells could destroy BM cells taken from Ia 
"knockout" (Ia  ~  mice; the Ia  ~ line used was backcrossed to 
the B6 background  (12). 
As shown in Table 5, BM cells from this line were com- 
pletely resistant to the cytotoxic effects of bin12 CD4 + cells. 
Thus,  whereas bm12 § CD4 § cells caused marked marrow 
and  spleen  atrophy  when  transferred  to  600  cGy (B6  x 
bm12)F1 mice with B6 BM cells,  transferring  bm12 CD4 + 
cells with B6 Ia  ~ BM cells caused no sign of marrow atrophy 
and led to  splenomegaly (Table  5,  Exp.  1 and 2).  Control 
experiments indicated that the B6 Ia  ~ BM ceUs retained sen- 
sitivity to marrow aplasia directed to class I antigens. Thus, 
as with B6 BM cells,  transferring  B6 Ia  ~ BM cells  to 600 
cGy (B6  x  bml)F1 hosts in the presence of bin1 CD8 + cells 
led to marked marrow  atrophy (Table 5,  Exp.  3). 
A  Search for Nonspecific  Destruction of Donor BM Cells by 
CD4 + Cells.  To assess the possibility that the destruction 
of BM cells by CD4 + ceils reflected a subtle bystander reac- 
tion, we reconstituted 600 cGy (B6  x  bm12)F1 mice with 
B6-Ly 5.1 BM cells  __ B6 CD4 + cells and then studied the 
kinetics  of the appearance  of the donor Ly 5.1 + BM cells 
in the host marrow by FACS  |  analysis.  If the destruction 
of the host marrow by CD4 + cells reflected  a bystander reac- 
tion rather than direct CTL activity, this reaction would be 
expected to impede engraftment by the donor B6-Ly 5.1 BM 
cells.  However, counting  total numbers of Ly 5.1 + cells in 
the host long bones during the period of rapid engraftment 
(days 6-15) showed little or no evidence that  the presence 
of B6 CD4 + cells impaired engraftment with B6-Ly 5.1 BM 
cells. 
Discussion 
This article documents that small doses of normal CD4 + 
cells transferred to lightly irradiated Ia-different hosts caused 
profound  atrophy  of host  hemopoietic cells  2-3  wk after 
transfer.  By all parameters studied, the destruction of hemo- 
poietic cells  by CD4 + cells  was limited  to  Ia + host ceils. 
Evidence for bystander damage of donor BM-derived cells 
or Ia-  host cells was conspicuously absent.  The key ques- 
tion  is  whether  the  injected  CD4 +  ceils  destroyed 
hemopoietic cells via direct  Ia-restricted  CTL activity. 
The  notion  that  the  injected  CD4 +  cells  killed  host 
hemopoietic ceils via direct CTL activity strains credulity when 
it is borne in mind  that  complete marrow  atrophy in the 
B6/bm12 combination was induced by as few as 7  x  104 
CD4 + cells.  Thus,  taking  into consideration  the extensive 
size of the host marrow, it is extremely difficult to envisage 
how the antigen-reactive  progeny of such a conspicuously 
small dose of CD4 + cells caused virtually complete destruc- 
tion of host marrow cells in a brief period, i.e.,  during the 
second week after transfer.  Surely one has to argue in terms 
of cell destruction by humoral  factors? 
In this respect, perhaps the simplest possibility is that the 
host cells were destroyed through the production of anti-Ia 
antibody, i.e., by donor-derived B cells. There are three cru- 
cial problems with  this idea.  First,  given that  the injected 
CD4 +  cells  were  effective in  very  small  doses  and  were 
highly purified, the number of contaminating B cells in the 
injected CD4 § cells must have been extremely low. More- 
over,  the  purification  method  used to  prepare  the  CD4 + 
cells included treatment  with anti-Ia mAb plus C  in doses 
sufficient  to  kill  >95%  of spleen B  cells.  Second,  to  our 
knowledge the antigenic difference between I-A and I-A  bin12 
is serologically undetectable. Third,  and most importantly, 
we have been unable to detect antibody activity in the serum 
of irradiated (B6  x  bm12)F1 hosts injected with B6 CD4 § 
cells (data not shown). For these reasons, it is very difficult 
to  sustain  the  argument  that  host  hemopoietic  cells  were 
destroyed via anti-Ia antibody. It is also worth noting that 
treating normal or lymphokine-induced BM cells with high 
concentrations of anti-Ia mAb plus C failed to impair stem 
cell activity. Yet stem cells appeared to be one of the main 
targets  of attack by CD4 + cells  (see below). 
Another possibility is that hemopoietic cells were destroyed 
via local production  of toxic cytokines such as TNF.  This 
notion  deserves serious consideration  because anti-TNF-c~ 
mAb is reported to be highly effective in preventing  some 
of the in vivo effector functions  of CD4 + cells,  e.g.,  gut 
damage associated with GVHD (19). The chief problem with 
the idea that tissue destruction reflected local production of 
toxic cytokines is that bystander damage by CD4 + cells ap- 
peared to be remarkably limited.  Thus the disapperance of 
host hemopoietic cells in the marrow did not seem to injure 
host stromal cells or cause significant impairment  of donor 
BM-derived  repopulation  of marrow  and  thymus.  These 
findings,  plus the failure of CD4 + cells to destroy residual 
radioresistant  host T  cells or host-type BM cells from Ia- 
deficient mice, strongly suggest that the destruction of host 
cells was directed exclusively to host Ia + cells. 
For the reasons cited above, it is very difficult to explain 
the destruction of hemopoietic cells by CD4 + cells in terms 
of humoral factors.  By exclusion, one is thus forced to con- 
sider the possibility that the injected CD4 + cells killed host 
hemopoietic cells via direct Ia-restricted  CTL activity. All 
of the available data are consistent with this possibility. The 
following model can be considered.  During the first week 
after transfer, the intravenously injected CD4 + cells homed 
to the spleen and became sensitized to host Ia antigens ex- 
pressed on dendritic cells. The host-reactive CD4 + cells then 
underwent considerable clonal expansion, differentiated into 
effector cells, and percolated throughout the body, including 
the  BM  (where  >50%  of the  cells  from  aplastic  marrow 
were donor CD4 § cells).  Through direct CTL activity, the 
effector cells then destroyed Ia + cells, leaving Ia-  host cells 
and Ia §  donor cells untouched. 
At least two objections can be raised against this scenario. 
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Figure 6.  Donor CD4 + cells fail to impede marrow engraftment of 
donor BM cells. (B6 x  bm12)F1 mice exposed to 600 cGy were injected 
with 2  x  106 B6-Ly 5.1 BM cells alone (O) or with a mixture of 2  x 
106 B6-Ly 5.1 BM cells and 2 x  106 B6 CD4 + cells (O). At the intervals 
shown, BM cells recovered  from both tibiae of two mice per group were 
counted and then stained for Ly 5.1 expression followed by FACS  |  anal- 
)'sis. The data shown were calculated from the percentage of Ly 5.1 + cells 
and the total BM counts. 
First, one has to explain how typical BM cells, most of which 
are largely Ia-, could be destroyed en masse by CD4 + cells. 
The explanation we favor here is that  the CTL activity of 
CD4 +  cells  is  directed predominantly  to various  types  of 
stem cells and/or their immediate progeny.  In the absence 
of stem cells,  the short-lived, terminally differentiated descen- 
dants of these cells rapidly disappear and hemopoietic failure 
results.  In support of this idea, we observed a marked pau- 
city  of stem  cells  in  the  atrophic  marrow  of mice  given 
CD4 § cells. It is disturbing,  however, that we failed to find 
evidence of Ia expression on stem cells by antibody plus C 
treatment or by panning. Moreover, studies in both humans 
(20) and mice (Spangrude, J., and I. Weissman, personal corn- 
munication) have found that purified pluripotential stem cells 
(nonlymphokine induced)  are Ia-  by FACS  |  analysis.  De- 
spite these findings, it is striking that the destruction of B6 
BM cells by bm12 CD4 + cells did not apply to B6 BM cells 
from Ia-deficient mice.  This finding strongly suggests that 
Ia expression on stem cells is physiologically significant and 
sufficient to act as a target for CD4 + cells. Since the stem 
cell targets for CD4 + cells in irradiated hosts are probably 
cycling and exposed to various cytokines, it would seem likely 
that Ia expression on stem cells has to be induced. In favor 
of this possibility,  it has been found that  Ia expression on 
human stem cells can be upregulated by lymphokines (20). 
We presume the same applies to mouse stem cells but this 
remains  to be proved. 
The second problem with the notion that CD4 § cells de- 
stroy hemopoietic cells via direct CTL activity is that we have 
had little success in demonstrating more than minimal CTL 
activity by CD4+cells  in vitro.  In  several experiments we 
observed significant class II-restricted lysis of tumor cells and 
LPS blasts by in vivo-sensitized CD4 + cells in the B6/bm12 
combination (our unpublished data).  However, the level of 
killing was quite low-far lower than for anti-class I killing 
by CD8 + cells-unless  the effector cells were restimulated 
with antigen in vitro. Yet Ia-restricted tissue destruction by 
CD4 + cells in vivo was as potent, or more potent, than the 
destruction  mediated by CD8 + cells responding to a class 
I difference. In view of this paradox, the existing techniques 
for demonstrating CTL activity by CD4 § cells in vitro may 
be a poor model for the in vivo functions of these cells (6). 
Whatever  the  explanation  for the  mechanism  of tissue 
destruction,  the  finding  that  very  small  doses  of CD4 § 
cells were capable of mediating massive Ia-restricted destruc- 
tion ofhemopoietic cells in irradiated hosts with no evidence 
of an overt bystander reaction indicates that the CTL activity 
of CD4 § cells in vivo is extremely potent.  Direct evidence 
on whether the CTL activity of CD4 + cells in vivo reflects 
direct lysis or the local release of humoral factors will have 
to await further investigation. As a footnote it may be men- 
tioned that destruction of stem cells by CD4 + CTL could 
explain the finding that BM engraftment across Ia barriers is 
enhanced when the recipients are depleted of CD4 + cells (21). 
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